A multicenter, randomized phase II trial of Avastin [bevacizumab] plus gemcitabine plus 5FU [fluorouracil]/folinic acid (A + FFG) vs. Avastin plus oxaliplatin + 5FU/folinic acid (A + FOLFOX4) as therapy for patients with metastatic colorectal cancer

Trial Profile

A multicenter, randomized phase II trial of Avastin [bevacizumab] plus gemcitabine plus 5FU [fluorouracil]/folinic acid (A + FFG) vs. Avastin plus oxaliplatin + 5FU/folinic acid (A + FOLFOX4) as therapy for patients with metastatic colorectal cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Feb 2011

At a glance

  • Drugs Bevacizumab; Fluorouracil; Folinic acid; Gemcitabine; Oxaliplatin
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 May 2009 Results presented at ASCO 2009.
    • 06 Jun 2007 Status changed from in progress to completed.
    • 28 Jul 2006 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top